Erich Sager

Erich Sager discloses dealings in 3 companies, chiefly Raptor Pharmaceutical Corp, Biomarin Pharmaceutical Inc and Raptor Pharmaceuticals Corp. The record holds 64 filings, for trades running from 1 December 2005 to 5 March 2015.

In open-market terms, that means 1 purchase worth €4,695 on one side and 43 sales worth €1.8M on the other. Sales outweigh purchases by €1.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 14 option exercises. So far in 2015, the count stands at no purchases and 1 sale.

The newest entry dates from 9 March 2015: an open-market sale of €242k, in Raptor Pharmaceutical Corp. The last purchase on record was published on 9 November 2006, which is 7,304 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.